Summary

Eligibility
for people ages 13-17 (full criteria)
Location
at UC Davis UCSF
Dates
study started
completion around
Principal Investigator
by Jenise C Wong, MD, PhD (ucsf)

Description

Summary

Diabetes technology, such as insulin pumps and continuous glucose monitoring devices, can help improve glucose control for people with type 1 diabetes (T1D), which keeps them at lower risk for diabetes complications, but many Latinx adolescents, who make up the largest marginalized ethnic group of youth with T1D in California, use these devices less often and have less optimal glucose control compared to White youth. In phase 1 of this project, we worked directly with Latinx youth, their families, and diabetes care team members in California to develop DREAM, Device use Reimagined through Education And Mentorship, a virtual peer group (VPG) intervention that will encourage and support the use of diabetes devices in Latinx adolescents with T1D. The goals for phase 2 (intervention) of this project are to evaluate the feasibility and acceptability of the stakeholder-informed VPG intervention, and evaluate clinical and person-centered outcomes.

Official Title

Optimizing Diabetes Technology Use for Latinx Youth Through DREAM (Device Use Reimagined Through Education And Mentorship) Virtual Peer Groups [Study-wide] - DREAM Intervention

Details

This multi-site project has two phases: phase 1 involved stakeholders focus groups to assess barriers and facilitators to diabetes technology and the creation of advisory councils. Feedback was obtained and used to develop phase 2, the single arm trial. A virtual peer group curriculum is being refined and will be implemented. The aims of this project are: (1) Partner with stakeholders to design a virtual peer group (VPG) intervention to promote the initiation and continued use of diabetes technology among Latinx adolescents with T1D. (2) Evaluate the feasibility and acceptability of DREAM VPGs in a pragmatic, single arm trial. (3) Assess the effects of DREAM VPGs on clinical and person-centered outcomes.

Our DREAM intervention will:

  • Build trust/rapport and "relational connections" between participants
  • Empower participants to be advocates in their/their adolescents' diabetes care
  • Provide tools/knowledge to navigate healthcare and diabetes technology systems
  • Increase knowledge, confidence, and interest in using diabetes technology
  • Create a culturally sensitive/inclusive VPG toolkit that will be scalable, feasible, and sustainable in broader clinical contexts if found to be beneficial

The DREAM project's findings will inform future efforts to improve diabetes technology use and T1D health outcomes among Latinx adolescents. If found to be effective, the VPG curriculum can be adapted for other clinic settings in order to improve education and peer support for Latinx patients and families. Future studies may extend or adapt DREAM to other cohorts, including other age groups, geographic settings, or marginalized and historically excluded populations with T1D.

Keywords

Diabetes Mellitus, Type 1, T1D, Diabetes, Diabetes Mellitus, Type 1, Type 1 Diabetes Mellitus, DREAM intervention

Eligibility

You can join if…

Open to people ages 13-17

  • Adolescents 13-17 years old and their caregivers
  • Adolescent must have T1D of any duration, and be receiving diabetes care at UCSF, CHLA or UC Davis
  • Self-identify as Latina/o/x or other variations such as Hispanic
  • Preferred language of English or Spanish

You CAN'T join if...

  • Participants who have a medical, developmental, or psychiatric condition that would make peer group participation difficult
  • Adolescents who are planning to transfer care to a different medical center within the next year, which would prevent assessment of longitudinal outcomes

Locations

  • University of California, Davis accepting new patients
    Davis California 95616 United States
  • University of California, San Francisco accepting new patients
    San Francisco California 94158 United States
  • Children's Hospital Los Angeles accepting new patients
    Los Angeles California 90027 United States

Lead Scientist at University of California Health

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06546930
Study Type
Interventional
Participants
Expecting 120 study participants
Last Updated